Lioe-Fee de Geus-Oei
Lioe-Fee de Geus-Oei
Professor in Radiology, with an emphasis on Nuclear Medicine at Leiden University Medical Center and Professor in Molecular Imaging, innovation and translation at the University of Twente, The Netherlands
Verified email at lumc.nl - Homepage
TitleCited byYear
Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review
LF de Geus-Oei, D Vriens, HWM van Laarhoven, WTA van der Graaf, ...
Journal of Nuclear Medicine 50 (Suppl 1), 43S-54S, 2009
2042009
A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin
CP Bleeker-Rovers, FJ Vos, AH Mudde, ASM Dofferhoff, LF de Geus-Oei, ...
European journal of nuclear medicine and molecular imaging 34 (5), 694-703, 2007
1932007
Biological correlates of FDG uptake in non-small cell lung cancer
LF de Geus-Oei, JHJM van Krieken, RP Aliredjo, PFM Krabbe, C Frielink, ...
Lung cancer 55 (1), 79-87, 2007
1882007
Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer
LF de Geus-Oei, HFM van der Heijden, EP Visser, R Hermsen, ...
Journal of nuclear medicine 48 (10), 1592-1598, 2007
1542007
Predictive and prognostic value of FDG‐PET in nonsmall‐cell lung cancer: a systematic review
LF de Geus‐Oei, HFM van der Heijden, FHM Corstens, WJG Oyen
Cancer 110 (8), 1654-1664, 2007
1492007
The role of 18fluoro‐2‐deoxyglucose positron emission tomography in initial staging and re‐staging after chemotherapy for testicular germ cell tumours
JR Spermon, LF De Geus‐Oei, L Kiemeney, JA Witjes, WJG Oyen
BJU international 89 (6), 549-556, 2002
1442002
18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results
LF de Geus-Oei, GFFM Pieters, JJ Bonenkamp, AH Mudde, ...
Journal of Nuclear Medicine 47 (5), 770-775, 2006
1342006
Chemotherapy response evaluation with FDG–PET in patients with colorectal cancer
LF de Geus-Oei, HWM van Laarhoven, EP Visser, R Hermsen, ...
Annals of oncology 19 (2), 348-352, 2008
1182008
18F-FDG PET early response evaluation of locally advanced non–small cell lung cancer treated with concomitant chemoradiotherapy
EA Usmanij, LF de Geus-Oei, EGC Troost, L Peters-Bax, ...
Journal of Nuclear Medicine 54 (9), 1528-1534, 2013
1022013
Scintigraphic techniques for early detection of cancer treatment–induced cardiotoxicity
LF de Geus-Oei, AMC Mavinkurve-Groothuis, L Bellersen, M Gotthardt, ...
Journal of Nuclear Medicine 52 (4), 560-571, 2011
972011
Methodological considerations in quantification of oncological FDG PET studies
D Vriens, EP Visser, LF de Geus-Oei, WJG Oyen
European journal of nuclear medicine and molecular imaging 37 (7), 1408-1425, 2010
972010
Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies
LF de Geus-Oei, EP Visser, PFM Krabbe, BA van Hoorn, EB Koenders, ...
Journal of Nuclear Medicine 47 (6), 945-949, 2006
942006
The role of [18F]‐2‐fluoro‐2‐deoxy‐d‐glucose–positron emission tomography in thyroid nodules with indeterminate fine‐needle aspiration biopsy: Systematic …
D Vriens, JHW de Wilt, GJ van der Wilt, RT Netea‐Maier, WJG Oyen, ...
Cancer 117 (20), 4582-4594, 2011
812011
Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use?
L Heijmen, MCHM Verstappen, EEGW Ter Voert, CJA Punt, WJG Oyen, ...
Critical reviews in oncology/hematology 83 (2), 194-207, 2012
752012
Differences in metabolism between adeno-and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4
TWH Meijer, OCJ Schuurbiers, JHAM Kaanders, MG Looijen-Salamon, ...
Lung cancer 76 (3), 316-323, 2012
752012
Predictive and prognostic value of FDG-PET
LF de Geus-Oei, WJG Oyen
Cancer Imaging 8 (1), 70, 2008
672008
EUS-FNA for the detection of left adrenal metastasis in patients with lung cancer
OCJ Schuurbiers, KG Tournoy, HJ Schoppers, BG Dijkman, ...
Lung Cancer 73 (3), 310-315, 2011
632011
Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma
OCJ Schuurbiers, TWH Meijer, JHAM Kaanders, MG Looijen-Salamon, ...
Journal of Thoracic Oncology 9 (10), 1485-1493, 2014
582014
A curve-fitting approach to estimate the arterial plasma input function for the assessment of glucose metabolic rate and response to treatment
D Vriens, LF de Geus-Oei, WJG Oyen, EP Visser
Journal of Nuclear Medicine 50 (12), 1933-1939, 2009
522009
FDG-PET in colorectal cancer
LF de Geus-Oei, TJM Ruers, CJA Punt, JW Leer, FHM Corstens, ...
Cancer Imaging 6 (Spec No A), S71, 2006
492006
The system can't perform the operation now. Try again later.
Articles 1–20